Morning Briefing
Summaries of health policy coverage from major news organizations
Findings Of Poor Quality Malaria Drugs In Africa Add To Artemisinin-Resistance Worries
A study released on Monday found that between 26 percent and 44 percent of artemisinin-based malaria drugs sold in Madagascar, Senegal and Uganda "failed quality testing" because of impurities or insufficient amounts of active ingredient, the Associated Press reports.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
